Revnuu specializes in commercializing breakthrough technologies and today has launched its Swiss business to tackle a critical blind spot in Europe’s innovation capital: the collapse of deep tech ventures between lab validation and market entry. The move responds to Switzerland’s world-leading deep tech funding surge (60% of national VC) amid a stark reality—90% of ventures fail pre-revenue, often due to communication breakdowns with investors and regulators.
The Silent Killer: Pre-Commercialization AmbiguityRevnuu’s Swiss launch targets two make-or-break phases where ventures hemorrhage capital and credibility:
PRE-PRODUCT / PRE-CLINICALTransforming proof-of-concept data into investor-ready narrativesRegulatory storytelling for ethics committees & grant bodiesPatent-to-pitch messaging for seed rounds
POST-PRODUCTScaling market entry with precision stakeholder targetingMitigating “pilot purgatory” in complex B2B sales cyclesBacked by a hybrid team of PhDs, ex-Fortune 500 strategists, and UNITS design collaborators, Revnuu de-risks these phases through:Fractional CMO Services: Embedded marketing leadership pre-during critical funding rounds.Regulatory Narrative Design: Translating preclinical data for IRBs, investors, and partners.Use Case and Application Development: Isolating high-impact applications from platform technologies
Why Basel? Why Now?Switzerland’s R&D dominance masks a commercialization crisis. The 2025 Swiss Deep Tech Report confirms:Basel, a global nexus of pharma, biotech, and materials science, demands tailored solutions for:Biotechs navigating preclinical communication to secure funding.Advanced Manufacturing ventures translating prototypes into industrial mission critical applications.Climate tech aligning IP with ESG funding requirements.
The Swiss Precision AdvantageRevnuu’s framework replaces jargon with market-driven storytelling:PRE-PRODUCT / PRE-CLINICAL SERVICESValue proposition for grant applicationsPre-IND communication playbooksInvestor pitch audits for deep tech VCsMarketing and Communication Plan DevelopmentFractional CMO services
POST-PRODUCT SCALINGCustomer acquisition strategiesPublic-funded project dissemination (Horizon Europe, Innosuisse)Impact-driven GTM strategy for deep tech ventures
About RevnuuFounded in Barcelona in 2021, now headquartered in Basel, Revnuu empowers deep tech pioneers — including early-stage ventures across biotech, photonics, advanced materials and AI — to turn scientific breakthroughs into market success. Revnuu has worked with over 55 global tech pioneers and has powered emerging deep tech companies globally.
Contact:
Revnuu Switzerland – Basel
www.revnuu.com
admin@revnuu.com
+34 605 232 344
This release is also available in German and French upon request.